Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines

Abaan, 2013, The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology, Cancer Res., 73, 4372, 10.1158/0008-5472.CAN-12-3342 Ardito, 2017, The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review), Int. J. Mol. Med., 40, 271, 10.3892/ijmm.2017.3036 Barretina, 2012, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, 483, 603, 10.1038/nature11003 Basta, 2015, The nucleosome remodeling and deacetylase complex in development and disease, Transl. Res., 165, 36, 10.1016/j.trsl.2014.05.003 Bates, 2015, Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data, Br. J. Haematol., 170, 96, 10.1111/bjh.13400 Borst, 2002, Mammalian ABC transporters in health and disease, Annu. Rev. Biochem., 71, 537, 10.1146/annurev.biochem.71.102301.093055 Brazma, 2003, ArrayExpress–a public repository for microarray gene expression data at the EBI, Nucleic Acids Res., 31, 68, 10.1093/nar/gkg091 Burton, 2018, NCI Comparative Oncology Program testing of non-camptothecin indenoisoquinoline topoisomerase i inhibitors in naturally occurring canine lymphoma, Clin. Cancer Res., 24, 5830, 10.1158/1078-0432.CCR-18-1498 Cancer Genome Atlas Research Network, 2013, The Cancer Genome Atlas Pan-Cancer analysis project, Nat. Genet., 45, 1113, 10.1038/ng.2764 Chang, 2016, Effect of beta-catenin silencing in overcoming radioresistance of head and neck cancer cells by antagonizing the effects of AMPK on Ku70/Ku80, Head Neck, 38, E1909, 10.1002/hed.24347 Chen, 2001, Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription, J. Cell Biol., 152, 87, 10.1083/jcb.152.1.87 Dudley, 2005, A global view of pleiotropy and phenotypically derived gene function in yeast, Mol. Syst. Biol., 1, 10.1038/msb4100004 Engers, 2000, Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression, Br. J. Cancer, 82, 1063, 10.1054/bjoc.1999.1043 Fojo, 2005, Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations, Crit. Rev. Oncol. Hematol., 53, 25, 10.1016/j.critrevonc.2004.09.008 Fraser, 2007, Using protein complexes to predict phenotypic effects of gene mutation, Genome Biol., 8, R252, 10.1186/gb-2007-8-11-r252 Gao, 2015, High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response, Nat. Med., 21, 1318, 10.1038/nm.3954 Garnett, 2012, Systematic identification of genomic markers of drug sensitivity in cancer cells, Nature, 483, 570, 10.1038/nature11005 Gholami, 2013, Global proteome analysis of the NCI-60 cell line panel, Cell Rep., 4, 609, 10.1016/j.celrep.2013.07.018 Gillet, 2012, Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis, Mol. Cell. Proteomics, 11, 10.1074/mcp.O111.016717 Guo, 2015, Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps, Nat. Med., 21, 407, 10.1038/nm.3807 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Holbeck, 2010, Analysis of Food and Drug Administration-approved anticancer agents in the NCI60 panel of human tumor cell lines, Mol. Cancer Ther., 9, 1451, 10.1158/1535-7163.MCT-10-0106 Huang, 2007, WNKs: protein kinases with a unique kinase domain, Exp. Mol. Med., 39, 565, 10.1038/emm.2007.62 Jang, 2014, Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data, Pac. Symp. Biocomput., 19, 63 Johnson, 2009, The regulation of protein phosphorylation, Biochem. Soc. Trans., 37, 627, 10.1042/BST0370627 Jones, 2006, PRIDE: a public repository of protein and peptide identifications for the proteomics community, Nucleic Acids Res., 34, D659, 10.1093/nar/gkj138 Kanungo, 2010, Exogenously expressed human Ku70 stabilizes Ku80 in Xenopus oocytes and induces heterologous DNA-PK catalytic activity, Mol. Cell Biochem., 338, 291, 10.1007/s11010-009-0363-3 Keller, 2002, Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search, Anal. Chem., 74, 5383, 10.1021/ac025747h Kosti, 2016, Cross-tissue analysis of gene and protein expression in normal and cancer tissues, Sci. Rep., 6, 24799, 10.1038/srep24799 Kuperstein, 2015, Atlas of cancer signalling network: a systems biology resource for integrative analysis of cancer data with google maps, Oncogenesis, 4, e160, 10.1038/oncsis.2015.19 Law, 2014, DrugBank 4.0: shedding new light on drug metabolism, Nucleic Acids Res., 42, D1091, 10.1093/nar/gkt1068 Le, 2015, A novel method for identifying disease associated protein complexes based on functional similarity protein complex networks, Algorithms Mol. Biol., 10, 14, 10.1186/s13015-015-0044-6 Lin, 2001, MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway, Oncogene, 20, 6559, 10.1038/sj.onc.1204818 Liu, 2016, On the dependency of cellular protein levels on mRNA abundance, Cell, 165, 535, 10.1016/j.cell.2016.03.014 Luna, 2015, rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R, Bioinformatics, 32, 1272, 10.1093/bioinformatics/btv701 Mackay, 2007, Targeting the protein kinase C family: are we there yet?, Nat. Rev. Cancer, 7, 554, 10.1038/nrc2168 Martignetti, 2016, ROMA: representation and quantification of module activity from target expression data, Front. Genet., 7, 18, 10.3389/fgene.2016.00018 Mertins, 2016, Proteogenomics connects somatic mutations to signalling in breast cancer, Nature, 534, 55, 10.1038/nature18003 Monks, 2018, The NCI transcriptional pharmacodynamics workbench: a tool to examine dynamic expression profiling of therapeutic response in the NCI-60 cell line panel, Cancer Res., 78, 6807, 10.1158/0008-5472.CAN-18-0989 Nishizuka, 2003, Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays, Proc. Natl. Acad. Sci. U S A, 100, 14229, 10.1073/pnas.2331323100 Ori, 2016, Spatiotemporal variation of mammalian protein complex stoichiometries, Genome Biol., 17, 47, 10.1186/s13059-016-0912-5 Papillon-Cavanagh, 2013, Comparison and validation of genomic predictors for anticancer drug sensitivity, J. Am. Med. Inform. Assoc., 20, 597, 10.1136/amiajnl-2012-001442 Picotti, 2012, Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions, Nat. Methods, 9, 555, 10.1038/nmeth.2015 Pommier, 2016, Roles of eukaryotic topoisomerases in transcription, replication and genomic stability, Nat. Rev. Mol. Cell Biol., 17, 703, 10.1038/nrm.2016.111 Powell, 2012, Pressure cycling technology in systems biology, Methods Mol. Biol., 881, 27, 10.1007/978-1-61779-827-6_2 Rajapakse, 2018, CellMinerCDB for integrative cross-database genomics and pharmacogenomics analyses of cancer cell lines, iScience, 10, 247, 10.1016/j.isci.2018.11.029 Reinhold, 2012, CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set, Cancer Res., 72, 3499, 10.1158/0008-5472.CAN-12-1370 Reinhold, 2019, RNA sequencing of the NCI-60: integration into CellMiner and CellMiner CDB, Cancer Res., 79, 3514, 10.1158/0008-5472.CAN-18-2047 Robey, 2018, Revisiting the role of ABC transporters in multidrug-resistant cancer, Nat. Rev. Cancer, 18, 452, 10.1038/s41568-018-0005-8 Rost, 2014, OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data, Nat. Biotechnol., 32, 219, 10.1038/nbt.2841 Schaeffer, 1998, MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade, Science, 281, 1668, 10.1126/science.281.5383.1668 Shankavaram, 2009, CellMiner: a relational database and query tool for the NCI-60 cancer cell lines, BMC Genomics, 10, 277, 10.1186/1471-2164-10-277 Shao, 2016, Reproducible tissue homogenization and protein extraction for quantitative proteomics using micropestle-assisted pressure-cycling technology, J. Proteome Res., 15, 1821, 10.1021/acs.jproteome.5b01136 Shao, 2015, Minimal sample requirement for highly multiplexed protein quantification in cell lines and tissues by PCT-SWATH mass spectrometry, Proteomics, 15, 3711, 10.1002/pmic.201500161 Shoemaker, 2006, The NCI60 human tumour cell line anticancer drug screen, Nat. Rev. Cancer, 6, 813, 10.1038/nrc1951 Tang, 2016, Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/beta-catenin signaling, J. Exp. Clin. Cancer Res., 35, 82, 10.1186/s13046-016-0344-9 Uhlen, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 1260419, 10.1126/science.1260419 Ummanni, 2012, Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro, J. Proteome Res., 11, 2452, 10.1021/pr201172n Wang, 2012, Community of protein complexes impacts disease association, Eur. J. Hum. Genet., 20, 1162, 10.1038/ejhg.2012.74 Weinstein, 2012, Drug discovery: cell lines battle cancer, Nature, 483, 544, 10.1038/483544a Xu, 2005, Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells, Mol. Cancer Ther., 4, 435, 10.1158/1535-7163.MCT-04-0280 Zhang, 2014, Proteogenomic characterization of human colon and rectal cancer, Nature, 513, 382, 10.1038/nature13438 Zhang, 2016, Integrated proteogenomic characterization of human high-grade serous ovarian cancer, Cell, 166, 755, 10.1016/j.cell.2016.05.069 Zoppoli, 2012, Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents, Proc. Natl. Acad. Sci. U S A, 109, 15030, 10.1073/pnas.1205943109